- Report
- November 2021
Germany
From €3328EUR$3,500USD£2,800GBP
- Report
- November 2021
France
From €3328EUR$3,500USD£2,800GBP
- Report
- November 2021
Japan, United States, ... Japan, United States, Europe, Global
From €23297EUR$24,500USD£19,600GBP
- Report
- November 2021
Canada, Mexico, North America Canada, Mexico, North America
From €9034EUR$9,500USD£7,600GBP
- Report
- November 2021
Middle East
From €9034EUR$9,500USD£7,600GBP
- Report
- November 2021
Latin America
From €13788EUR$14,500USD£11,600GBP
- Report
- November 2021
Europe
From €23297EUR$24,500USD£19,600GBP
- Report
- November 2021
Asia Pacific
From €13788EUR$14,500USD£11,600GBP
- Report
- November 2021
Global
From €32806EUR$34,500USD£27,600GBP
The Antithrombin Test is a coagulation and hemostasis test used to measure the activity of antithrombin, a protein in the blood that helps to prevent the formation of blood clots. It is used to diagnose and monitor conditions such as thrombophilia, a disorder that increases the risk of blood clots, and to assess the risk of thromboembolism, a condition in which a clot forms in a blood vessel and travels to another part of the body. The test is performed using a sample of blood, which is then analyzed in a laboratory.
The Antithrombin Test market is composed of a variety of companies that provide testing services, reagents, and instruments. These companies include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Ortho Clinical Diagnostics, Sysmex Corporation, and Grifols. Show Less Read more